Novo Nordisk’s drug helped reduce knee pain in osteoarthritis patients with obesity. Meanwhile, the Change Healthcare breach ...

Clinical-trial participants saw their knee pain abate and could engage better with activities that got them up and going.

Osteoarthritis, the most common form of arthritis, is primarily caused by wear and tear on the protective layer of cartilage ...

A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current ...

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss ...

People who lost a significant amount of weight with semaglutide saw major improvements in osteoarthritis knee pain, research ...

As OA progresses, it can lead to reduced mobility and bone spurs, further limiting movement. Arthritis includes over 100 ...

Arthritis typically leads to stiffness, inflammation and pain in joints, affecting one's mobility and agility. While it is a degenerative disease, there are effective ways to manage arthritis and ...

Semaglutide (Wegovy) reduced pain and improved physical function in patients with obesity and knee osteoarthritis, a ...

Morning stretches are a simple yet highly effective way to kickstart your day, promoting flexibility, reducing stiffness, and ...

Wegovy reduced arthritic knee pain in study subjects with high BMI. Unknown: the exact mechanism or whether it would prevent knee replacement surgery.